<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1622800568542 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td>VILLANUEVA_LIVER_CANCER_KRT19_UP</td><td><a href='VILLANUEVA_LIVER_CANCER_KRT19_UP.html'>Details ...</a></td><td>92</td><td>-0.46</td><td>-2.47</td><td>0.000</td><td>0.000</td><td>0.000</td><td>4345</td><td>tags=63%, list=32%, signal=92%</td></tr><tr><td class='lessen'>2</td><td>REACTOME_SIGNALING_BY_KIT_IN_DISEASE</td><td><a href='REACTOME_SIGNALING_BY_KIT_IN_DISEASE.html'>Details ...</a></td><td>16</td><td>-0.72</td><td>-2.44</td><td>0.000</td><td>0.000</td><td>0.000</td><td>3809</td><td>tags=100%, list=28%, signal=138%</td></tr><tr><td class='lessen'>3</td><td>KEGG_CHRONIC_MYELOID_LEUKEMIA</td><td><a href='KEGG_CHRONIC_MYELOID_LEUKEMIA.html'>Details ...</a></td><td>54</td><td>-0.47</td><td>-2.26</td><td>0.000</td><td>0.000</td><td>0.001</td><td>5780</td><td>tags=80%, list=42%, signal=137%</td></tr><tr><td class='lessen'>4</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td><a href='JISON_SICKLE_CELL_DISEASE_DN.html'>Details ...</a></td><td>117</td><td>-0.38</td><td>-2.15</td><td>0.000</td><td>0.001</td><td>0.005</td><td>4298</td><td>tags=55%, list=31%, signal=79%</td></tr><tr><td class='lessen'>5</td><td>BIOCARTA_NFAT_PATHWAY</td><td><a href='BIOCARTA_NFAT_PATHWAY.html'>Details ...</a></td><td>35</td><td>-0.51</td><td>-2.12</td><td>0.000</td><td>0.002</td><td>0.007</td><td>5686</td><td>tags=80%, list=42%, signal=136%</td></tr><tr><td class='lessen'>6</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td><a href='BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN.html'>Details ...</a></td><td>122</td><td>-0.37</td><td>-2.08</td><td>0.000</td><td>0.002</td><td>0.010</td><td>3783</td><td>tags=50%, list=28%, signal=68%</td></tr><tr><td class='lessen'>7</td><td>BILD_MYC_ONCOGENIC_SIGNATURE</td><td><a href='BILD_MYC_ONCOGENIC_SIGNATURE.html'>Details ...</a></td><td>135</td><td>-0.35</td><td>-2.02</td><td>0.000</td><td>0.003</td><td>0.019</td><td>5376</td><td>tags=64%, list=39%, signal=104%</td></tr><tr><td class='lessen'>8</td><td>BIOCARTA_GLEEVEC_PATHWAY</td><td><a href='BIOCARTA_GLEEVEC_PATHWAY.html'>Details ...</a></td><td>15</td><td>-0.60</td><td>-2.01</td><td>0.000</td><td>0.003</td><td>0.023</td><td>4360</td><td>tags=87%, list=32%, signal=127%</td></tr><tr><td class='lessen'>9</td><td>WP_ATM_SIGNALING_NETWORK_IN_DEVELOPMENT_AND_DISEASE</td><td><a href='WP_ATM_SIGNALING_NETWORK_IN_DEVELOPMENT_AND_DISEASE.html'>Details ...</a></td><td>22</td><td>-0.53</td><td>-1.97</td><td>0.001</td><td>0.006</td><td>0.043</td><td>5209</td><td>tags=82%, list=38%, signal=132%</td></tr><tr><td class='lessen'>10</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td><a href='ZHAN_MULTIPLE_MYELOMA_SUBGROUPS.html'>Details ...</a></td><td>24</td><td>-0.51</td><td>-1.97</td><td>0.001</td><td>0.006</td><td>0.052</td><td>4594</td><td>tags=71%, list=34%, signal=106%</td></tr><tr><td class='lessen'>11</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP</td><td><a href='GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP.html'>Details ...</a></td><td>140</td><td>-0.34</td><td>-1.95</td><td>0.000</td><td>0.008</td><td>0.072</td><td>7514</td><td>tags=76%, list=55%, signal=168%</td></tr><tr><td class='lessen'>12</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td><a href='GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN.html'>Details ...</a></td><td>305</td><td>-0.30</td><td>-1.95</td><td>0.000</td><td>0.007</td><td>0.073</td><td>5199</td><td>tags=52%, list=38%, signal=82%</td></tr><tr><td class='lessen'>13</td><td>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</td><td><a href='ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER.html'>Details ...</a></td><td>87</td><td>-0.37</td><td>-1.94</td><td>0.000</td><td>0.007</td><td>0.074</td><td>4345</td><td>tags=54%, list=32%, signal=79%</td></tr><tr><td class='lessen'>14</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP</td><td><a href='GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP.html'>Details ...</a></td><td>154</td><td>-0.33</td><td>-1.93</td><td>0.000</td><td>0.008</td><td>0.094</td><td>6382</td><td>tags=65%, list=47%, signal=120%</td></tr><tr><td class='lessen'>15</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP</td><td><a href='GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP.html'>Details ...</a></td><td>148</td><td>-0.33</td><td>-1.92</td><td>0.000</td><td>0.008</td><td>0.105</td><td>4298</td><td>tags=49%, list=31%, signal=71%</td></tr><tr><td class='lessen'>16</td><td>GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN</td><td><a href='GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN.html'>Details ...</a></td><td>120</td><td>-0.34</td><td>-1.91</td><td>0.000</td><td>0.009</td><td>0.113</td><td>6160</td><td>tags=64%, list=45%, signal=116%</td></tr><tr><td class='lessen'>17</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td><a href='CHANDRAN_METASTASIS_TOP50_UP.html'>Details ...</a></td><td>24</td><td>-0.49</td><td>-1.88</td><td>0.003</td><td>0.012</td><td>0.158</td><td>4002</td><td>tags=67%, list=29%, signal=94%</td></tr><tr><td class='lessen'>18</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP</td><td><a href='GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP.html'>Details ...</a></td><td>135</td><td>-0.33</td><td>-1.88</td><td>0.000</td><td>0.011</td><td>0.161</td><td>6367</td><td>tags=65%, list=46%, signal=121%</td></tr><tr><td class='lessen'>19</td><td>WP_PRION_DISEASE_PATHWAY</td><td><a href='WP_PRION_DISEASE_PATHWAY.html'>Details ...</a></td><td>20</td><td>-0.50</td><td>-1.87</td><td>0.006</td><td>0.011</td><td>0.168</td><td>6042</td><td>tags=80%, list=44%, signal=143%</td></tr><tr><td class='lessen'>20</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td><a href='ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN.html'>Details ...</a></td><td>48</td><td>-0.40</td><td>-1.85</td><td>0.001</td><td>0.013</td><td>0.208</td><td>6319</td><td>tags=75%, list=46%, signal=139%</td></tr><tr><td class='lessen'>21</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN</td><td></td><td>130</td><td>-0.32</td><td>-1.84</td><td>0.000</td><td>0.014</td><td>0.230</td><td>5757</td><td>tags=64%, list=42%, signal=109%</td></tr><tr><td class='lessen'>22</td><td>HP_SPORADIC</td><td></td><td>59</td><td>-0.37</td><td>-1.84</td><td>0.001</td><td>0.014</td><td>0.234</td><td>5430</td><td>tags=61%, list=40%, signal=101%</td></tr><tr><td class='lessen'>23</td><td>KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS</td><td></td><td>36</td><td>-0.42</td><td>-1.83</td><td>0.001</td><td>0.015</td><td>0.265</td><td>3878</td><td>tags=56%, list=28%, signal=77%</td></tr><tr><td class='lessen'>24</td><td>FAELT_B_CLL_WITH_VH3_21_UP</td><td></td><td>27</td><td>-0.47</td><td>-1.83</td><td>0.000</td><td>0.015</td><td>0.272</td><td>5062</td><td>tags=70%, list=37%, signal=111%</td></tr><tr><td class='lessen'>25</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>117</td><td>-0.32</td><td>-1.81</td><td>0.000</td><td>0.019</td><td>0.332</td><td>7369</td><td>tags=78%, list=54%, signal=167%</td></tr><tr><td class='lessen'>26</td><td>SU_TESTIS</td><td></td><td>47</td><td>-0.39</td><td>-1.81</td><td>0.001</td><td>0.019</td><td>0.337</td><td>7421</td><td>tags=83%, list=54%, signal=180%</td></tr><tr><td class='lessen'>27</td><td>ANDERSEN_LIVER_CANCER_KRT19_UP</td><td></td><td>33</td><td>-0.43</td><td>-1.80</td><td>0.004</td><td>0.020</td><td>0.369</td><td>7424</td><td>tags=91%, list=54%, signal=198%</td></tr><tr><td class='lessen'>28</td><td>BIOCARTA_MCALPAIN_PATHWAY</td><td></td><td>16</td><td>-0.53</td><td>-1.79</td><td>0.004</td><td>0.020</td><td>0.377</td><td>5160</td><td>tags=88%, list=38%, signal=140%</td></tr><tr><td class='lessen'>29</td><td>VANTVEER_BREAST_CANCER_POOR_PROGNOSIS</td><td></td><td>34</td><td>-0.41</td><td>-1.78</td><td>0.001</td><td>0.022</td><td>0.423</td><td>4587</td><td>tags=59%, list=33%, signal=88%</td></tr><tr><td class='lessen'>30</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>23</td><td>-0.47</td><td>-1.78</td><td>0.006</td><td>0.022</td><td>0.425</td><td>4465</td><td>tags=61%, list=33%, signal=90%</td></tr><tr><td class='lessen'>31</td><td>REACTOME_INFECTIOUS_DISEASE</td><td></td><td>647</td><td>-0.26</td><td>-1.77</td><td>0.000</td><td>0.022</td><td>0.432</td><td>3927</td><td>tags=36%, list=29%, signal=48%</td></tr><tr><td class='lessen'>32</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>264</td><td>-0.28</td><td>-1.77</td><td>0.000</td><td>0.022</td><td>0.447</td><td>6086</td><td>tags=59%, list=44%, signal=104%</td></tr><tr><td class='lessen'>33</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP</td><td></td><td>149</td><td>-0.30</td><td>-1.76</td><td>0.002</td><td>0.022</td><td>0.457</td><td>5810</td><td>tags=57%, list=42%, signal=98%</td></tr><tr><td class='lessen'>34</td><td>ZHAN_MULTIPLE_MYELOMA_UP</td><td></td><td>38</td><td>-0.40</td><td>-1.74</td><td>0.005</td><td>0.026</td><td>0.516</td><td>2938</td><td>tags=45%, list=21%, signal=57%</td></tr><tr><td class='lessen'>35</td><td>WONG_PROTEASOME_GENE_MODULE</td><td></td><td>41</td><td>-0.40</td><td>-1.74</td><td>0.000</td><td>0.026</td><td>0.528</td><td>6373</td><td>tags=73%, list=47%, signal=136%</td></tr><tr><td class='lessen'>36</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN</td><td></td><td>124</td><td>-0.30</td><td>-1.74</td><td>0.000</td><td>0.026</td><td>0.537</td><td>5879</td><td>tags=59%, list=43%, signal=102%</td></tr><tr><td class='lessen'>37</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>522</td><td>-0.26</td><td>-1.74</td><td>0.000</td><td>0.026</td><td>0.539</td><td>5940</td><td>tags=57%, list=43%, signal=96%</td></tr><tr><td class='lessen'>38</td><td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td><td></td><td>33</td><td>-0.41</td><td>-1.73</td><td>0.007</td><td>0.026</td><td>0.561</td><td>6315</td><td>tags=73%, list=46%, signal=135%</td></tr><tr><td class='lessen'>39</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP</td><td></td><td>249</td><td>-0.28</td><td>-1.73</td><td>0.001</td><td>0.026</td><td>0.568</td><td>4872</td><td>tags=49%, list=36%, signal=75%</td></tr><tr><td class='lessen'>40</td><td>REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS</td><td></td><td>20</td><td>-0.47</td><td>-1.72</td><td>0.019</td><td>0.027</td><td>0.595</td><td>2288</td><td>tags=40%, list=17%, signal=48%</td></tr><tr><td class='lessen'>41</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>234</td><td>-0.27</td><td>-1.71</td><td>0.000</td><td>0.031</td><td>0.639</td><td>6366</td><td>tags=58%, list=46%, signal=107%</td></tr><tr><td class='lessen'>42</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>264</td><td>-0.27</td><td>-1.69</td><td>0.000</td><td>0.034</td><td>0.683</td><td>4766</td><td>tags=48%, list=35%, signal=73%</td></tr><tr><td class='lessen'>43</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP</td><td></td><td>128</td><td>-0.30</td><td>-1.69</td><td>0.000</td><td>0.035</td><td>0.702</td><td>6761</td><td>tags=73%, list=49%, signal=142%</td></tr><tr><td class='lessen'>44</td><td>GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP</td><td></td><td>106</td><td>-0.31</td><td>-1.69</td><td>0.005</td><td>0.034</td><td>0.703</td><td>6005</td><td>tags=65%, list=44%, signal=115%</td></tr><tr><td class='lessen'>45</td><td>GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN</td><td></td><td>125</td><td>-0.30</td><td>-1.69</td><td>0.004</td><td>0.033</td><td>0.704</td><td>4048</td><td>tags=44%, list=30%, signal=62%</td></tr><tr><td class='lessen'>46</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP</td><td></td><td>148</td><td>-0.29</td><td>-1.67</td><td>0.004</td><td>0.037</td><td>0.755</td><td>4130</td><td>tags=45%, list=30%, signal=63%</td></tr><tr><td class='lessen'>47</td><td>WP_ALZHEIMERS_DISEASE</td><td></td><td>50</td><td>-0.36</td><td>-1.67</td><td>0.011</td><td>0.040</td><td>0.787</td><td>3669</td><td>tags=52%, list=27%, signal=71%</td></tr><tr><td class='lessen'>48</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN</td><td></td><td>128</td><td>-0.30</td><td>-1.66</td><td>0.002</td><td>0.039</td><td>0.789</td><td>7215</td><td>tags=66%, list=53%, signal=137%</td></tr><tr><td class='lessen'>49</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td><td></td><td>28</td><td>-0.42</td><td>-1.65</td><td>0.012</td><td>0.042</td><td>0.822</td><td>6062</td><td>tags=71%, list=44%, signal=128%</td></tr><tr><td class='lessen'>50</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN</td><td></td><td>124</td><td>-0.29</td><td>-1.65</td><td>0.001</td><td>0.044</td><td>0.838</td><td>6105</td><td>tags=61%, list=45%, signal=110%</td></tr><tr><td class='lessen'>51</td><td>GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN</td><td></td><td>116</td><td>-0.29</td><td>-1.65</td><td>0.002</td><td>0.043</td><td>0.839</td><td>6154</td><td>tags=61%, list=45%, signal=110%</td></tr><tr><td class='lessen'>52</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN</td><td></td><td>133</td><td>-0.29</td><td>-1.64</td><td>0.002</td><td>0.044</td><td>0.843</td><td>7215</td><td>tags=68%, list=53%, signal=142%</td></tr><tr><td class='lessen'>53</td><td>VANTVEER_BREAST_CANCER_BRCA1_UP</td><td></td><td>26</td><td>-0.42</td><td>-1.64</td><td>0.022</td><td>0.044</td><td>0.853</td><td>4697</td><td>tags=62%, list=34%, signal=93%</td></tr><tr><td class='lessen'>54</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN</td><td></td><td>65</td><td>-0.33</td><td>-1.63</td><td>0.006</td><td>0.045</td><td>0.866</td><td>6718</td><td>tags=69%, list=49%, signal=135%</td></tr><tr><td class='lessen'>55</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN</td><td></td><td>36</td><td>-0.38</td><td>-1.63</td><td>0.014</td><td>0.045</td><td>0.870</td><td>5013</td><td>tags=61%, list=37%, signal=96%</td></tr><tr><td class='lessen'>56</td><td>WP_PARKINSONS_DISEASE_PATHWAY</td><td></td><td>31</td><td>-0.39</td><td>-1.63</td><td>0.017</td><td>0.044</td><td>0.870</td><td>5976</td><td>tags=71%, list=44%, signal=126%</td></tr><tr><td class='lessen'>57</td><td>GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP</td><td></td><td>119</td><td>-0.29</td><td>-1.62</td><td>0.005</td><td>0.048</td><td>0.897</td><td>5244</td><td>tags=49%, list=38%, signal=78%</td></tr><tr><td class='lessen'>58</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN</td><td></td><td>34</td><td>-0.38</td><td>-1.62</td><td>0.010</td><td>0.048</td><td>0.901</td><td>6664</td><td>tags=74%, list=49%, signal=143%</td></tr><tr><td class='lessen'>59</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN</td><td></td><td>107</td><td>-0.29</td><td>-1.62</td><td>0.005</td><td>0.048</td><td>0.901</td><td>3504</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>60</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>929</td><td>-0.23</td><td>-1.61</td><td>0.000</td><td>0.048</td><td>0.904</td><td>5525</td><td>tags=47%, list=40%, signal=73%</td></tr><tr><td class='lessen'>61</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN</td><td></td><td>137</td><td>-0.28</td><td>-1.60</td><td>0.004</td><td>0.053</td><td>0.932</td><td>5950</td><td>tags=57%, list=43%, signal=100%</td></tr><tr><td class='lessen'>62</td><td>REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE</td><td></td><td>23</td><td>-0.43</td><td>-1.60</td><td>0.024</td><td>0.052</td><td>0.936</td><td>3809</td><td>tags=52%, list=28%, signal=72%</td></tr><tr><td class='lessen'>63</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6</td><td></td><td>15</td><td>-0.49</td><td>-1.59</td><td>0.039</td><td>0.053</td><td>0.945</td><td>6664</td><td>tags=93%, list=49%, signal=182%</td></tr><tr><td class='lessen'>64</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN</td><td></td><td>129</td><td>-0.27</td><td>-1.57</td><td>0.011</td><td>0.064</td><td>0.968</td><td>6973</td><td>tags=64%, list=51%, signal=130%</td></tr><tr><td class='lessen'>65</td><td>SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>82</td><td>-0.30</td><td>-1.57</td><td>0.008</td><td>0.065</td><td>0.970</td><td>7382</td><td>tags=72%, list=54%, signal=155%</td></tr><tr><td class='lessen'>66</td><td>KYNG_RESPONSE_TO_H2O2</td><td></td><td>56</td><td>-0.32</td><td>-1.56</td><td>0.031</td><td>0.065</td><td>0.972</td><td>6664</td><td>tags=70%, list=49%, signal=135%</td></tr><tr><td class='lessen'>67</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN</td><td></td><td>129</td><td>-0.27</td><td>-1.56</td><td>0.015</td><td>0.068</td><td>0.975</td><td>5902</td><td>tags=57%, list=43%, signal=99%</td></tr><tr><td class='lessen'>68</td><td>SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE</td><td></td><td>55</td><td>-0.33</td><td>-1.55</td><td>0.022</td><td>0.070</td><td>0.980</td><td>3445</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>69</td><td>GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN</td><td></td><td>134</td><td>-0.27</td><td>-1.55</td><td>0.006</td><td>0.070</td><td>0.981</td><td>4463</td><td>tags=46%, list=33%, signal=67%</td></tr><tr><td class='lessen'>70</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>416</td><td>-0.23</td><td>-1.54</td><td>0.000</td><td>0.077</td><td>0.988</td><td>4939</td><td>tags=44%, list=36%, signal=67%</td></tr><tr><td class='lessen'>71</td><td>GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN</td><td></td><td>121</td><td>-0.27</td><td>-1.53</td><td>0.017</td><td>0.079</td><td>0.990</td><td>5712</td><td>tags=53%, list=42%, signal=90%</td></tr><tr><td class='lessen'>72</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP</td><td></td><td>140</td><td>-0.26</td><td>-1.51</td><td>0.008</td><td>0.088</td><td>0.996</td><td>3439</td><td>tags=39%, list=25%, signal=51%</td></tr><tr><td class='lessen'>73</td><td>GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP</td><td></td><td>144</td><td>-0.26</td><td>-1.51</td><td>0.012</td><td>0.090</td><td>0.997</td><td>6848</td><td>tags=65%, list=50%, signal=129%</td></tr><tr><td class='lessen'>74</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN</td><td></td><td>132</td><td>-0.26</td><td>-1.50</td><td>0.018</td><td>0.097</td><td>1.000</td><td>6909</td><td>tags=66%, list=50%, signal=132%</td></tr><tr><td class='lessen'>75</td><td>CROMER_METASTASIS_DN</td><td></td><td>55</td><td>-0.31</td><td>-1.50</td><td>0.031</td><td>0.096</td><td>1.000</td><td>7075</td><td>tags=76%, list=52%, signal=157%</td></tr><tr><td class='lessen'>76</td><td>LI_LUNG_CANCER</td><td></td><td>34</td><td>-0.35</td><td>-1.50</td><td>0.045</td><td>0.096</td><td>1.000</td><td>8100</td><td>tags=85%, list=59%, signal=208%</td></tr><tr><td class='lessen'>77</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN</td><td></td><td>115</td><td>-0.26</td><td>-1.48</td><td>0.019</td><td>0.110</td><td>1.000</td><td>6068</td><td>tags=54%, list=44%, signal=96%</td></tr><tr><td class='lessen'>78</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>58</td><td>-0.30</td><td>-1.47</td><td>0.040</td><td>0.109</td><td>1.000</td><td>5908</td><td>tags=62%, list=43%, signal=109%</td></tr><tr><td class='lessen'>79</td><td>GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN</td><td></td><td>121</td><td>-0.26</td><td>-1.47</td><td>0.021</td><td>0.109</td><td>1.000</td><td>4141</td><td>tags=41%, list=30%, signal=59%</td></tr><tr><td class='lessen'>80</td><td>BIOCARTA_NTHI_PATHWAY</td><td></td><td>19</td><td>-0.41</td><td>-1.47</td><td>0.060</td><td>0.108</td><td>1.000</td><td>7673</td><td>tags=84%, list=56%, signal=191%</td></tr><tr><td class='lessen'>81</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>226</td><td>-0.23</td><td>-1.47</td><td>0.015</td><td>0.113</td><td>1.000</td><td>6894</td><td>tags=58%, list=50%, signal=116%</td></tr><tr><td class='lessen'>82</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE</td><td></td><td>62</td><td>-0.29</td><td>-1.46</td><td>0.035</td><td>0.120</td><td>1.000</td><td>3000</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>83</td><td>ZHAN_MULTIPLE_MYELOMA_PR_UP</td><td></td><td>32</td><td>-0.35</td><td>-1.46</td><td>0.055</td><td>0.119</td><td>1.000</td><td>4287</td><td>tags=53%, list=31%, signal=77%</td></tr><tr><td class='lessen'>84</td><td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td><td></td><td>55</td><td>-0.31</td><td>-1.45</td><td>0.043</td><td>0.118</td><td>1.000</td><td>5493</td><td>tags=58%, list=40%, signal=97%</td></tr><tr><td class='lessen'>85</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>199</td><td>-0.24</td><td>-1.45</td><td>0.017</td><td>0.117</td><td>1.000</td><td>5655</td><td>tags=50%, list=41%, signal=84%</td></tr><tr><td class='lessen'>86</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>204</td><td>-0.24</td><td>-1.45</td><td>0.014</td><td>0.116</td><td>1.000</td><td>7168</td><td>tags=64%, list=52%, signal=133%</td></tr><tr><td class='lessen'>87</td><td>JISON_SICKLE_CELL_DISEASE_UP</td><td></td><td>156</td><td>-0.25</td><td>-1.45</td><td>0.018</td><td>0.119</td><td>1.000</td><td>3260</td><td>tags=35%, list=24%, signal=45%</td></tr><tr><td class='lessen'>88</td><td>VANTVEER_BREAST_CANCER_METASTASIS_DN</td><td></td><td>77</td><td>-0.28</td><td>-1.45</td><td>0.044</td><td>0.121</td><td>1.000</td><td>4835</td><td>tags=52%, list=35%, signal=80%</td></tr><tr><td class='lessen'>89</td><td>GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN</td><td></td><td>134</td><td>-0.25</td><td>-1.44</td><td>0.038</td><td>0.121</td><td>1.000</td><td>5834</td><td>tags=58%, list=43%, signal=100%</td></tr><tr><td class='lessen'>90</td><td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td><td></td><td>27</td><td>-0.36</td><td>-1.44</td><td>0.069</td><td>0.125</td><td>1.000</td><td>7036</td><td>tags=81%, list=51%, signal=167%</td></tr><tr><td class='lessen'>91</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>76</td><td>-0.27</td><td>-1.43</td><td>0.046</td><td>0.128</td><td>1.000</td><td>5903</td><td>tags=54%, list=43%, signal=94%</td></tr><tr><td class='lessen'>92</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP</td><td></td><td>166</td><td>-0.24</td><td>-1.43</td><td>0.029</td><td>0.133</td><td>1.000</td><td>5853</td><td>tags=54%, list=43%, signal=92%</td></tr><tr><td class='lessen'>93</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN</td><td></td><td>120</td><td>-0.25</td><td>-1.41</td><td>0.048</td><td>0.143</td><td>1.000</td><td>7300</td><td>tags=64%, list=53%, signal=136%</td></tr><tr><td class='lessen'>94</td><td>KEGG_PRION_DISEASES</td><td></td><td>27</td><td>-0.36</td><td>-1.41</td><td>0.084</td><td>0.146</td><td>1.000</td><td>4153</td><td>tags=48%, list=30%, signal=69%</td></tr><tr><td class='lessen'>95</td><td>REACTOME_SIGNALING_BY_FGFR_IN_DISEASE</td><td></td><td>42</td><td>-0.32</td><td>-1.41</td><td>0.080</td><td>0.147</td><td>1.000</td><td>4790</td><td>tags=45%, list=35%, signal=69%</td></tr><tr><td class='lessen'>96</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>50</td><td>-0.30</td><td>-1.40</td><td>0.085</td><td>0.149</td><td>1.000</td><td>6011</td><td>tags=62%, list=44%, signal=110%</td></tr><tr><td class='lessen'>97</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>164</td><td>-0.24</td><td>-1.40</td><td>0.025</td><td>0.150</td><td>1.000</td><td>4934</td><td>tags=46%, list=36%, signal=72%</td></tr><tr><td class='lessen'>98</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>307</td><td>-0.22</td><td>-1.40</td><td>0.016</td><td>0.151</td><td>1.000</td><td>4935</td><td>tags=41%, list=36%, signal=63%</td></tr><tr><td class='lessen'>99</td><td>GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP</td><td></td><td>110</td><td>-0.25</td><td>-1.40</td><td>0.035</td><td>0.150</td><td>1.000</td><td>6916</td><td>tags=61%, list=50%, signal=122%</td></tr><tr><td class='lessen'>100</td><td>VANTVEER_BREAST_CANCER_BRCA1_DN</td><td></td><td>25</td><td>-0.36</td><td>-1.39</td><td>0.089</td><td>0.155</td><td>1.000</td><td>7158</td><td>tags=64%, list=52%, signal=134%</td></tr><tr><td class='lessen'>101</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>542</td><td>-0.20</td><td>-1.38</td><td>0.004</td><td>0.165</td><td>1.000</td><td>5998</td><td>tags=51%, list=44%, signal=86%</td></tr><tr><td class='lessen'>102</td><td>SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP</td><td></td><td>15</td><td>-0.42</td><td>-1.38</td><td>0.103</td><td>0.168</td><td>1.000</td><td>6350</td><td>tags=73%, list=46%, signal=137%</td></tr><tr><td class='lessen'>103</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>295</td><td>-0.21</td><td>-1.37</td><td>0.022</td><td>0.170</td><td>1.000</td><td>6111</td><td>tags=52%, list=45%, signal=92%</td></tr><tr><td class='lessen'>104</td><td>GSE15659_RESTING_VS_ACTIVATED_TREG_DN</td><td></td><td>135</td><td>-0.24</td><td>-1.37</td><td>0.042</td><td>0.176</td><td>1.000</td><td>5928</td><td>tags=52%, list=43%, signal=91%</td></tr><tr><td class='lessen'>105</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>29</td><td>-0.33</td><td>-1.36</td><td>0.110</td><td>0.176</td><td>1.000</td><td>6184</td><td>tags=62%, list=45%, signal=113%</td></tr><tr><td class='lessen'>106</td><td>HP_AVASCULAR_NECROSIS</td><td></td><td>41</td><td>-0.31</td><td>-1.36</td><td>0.090</td><td>0.180</td><td>1.000</td><td>5017</td><td>tags=49%, list=37%, signal=77%</td></tr><tr><td class='lessen'>107</td><td>HECKER_IFNB1_TARGETS</td><td></td><td>78</td><td>-0.27</td><td>-1.35</td><td>0.074</td><td>0.184</td><td>1.000</td><td>5627</td><td>tags=53%, list=41%, signal=89%</td></tr><tr><td class='lessen'>108</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP</td><td></td><td>34</td><td>-0.32</td><td>-1.35</td><td>0.098</td><td>0.183</td><td>1.000</td><td>5894</td><td>tags=65%, list=43%, signal=113%</td></tr><tr><td class='lessen'>109</td><td>GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP</td><td></td><td>93</td><td>-0.25</td><td>-1.35</td><td>0.076</td><td>0.185</td><td>1.000</td><td>6553</td><td>tags=59%, list=48%, signal=113%</td></tr><tr><td class='lessen'>110</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN</td><td></td><td>41</td><td>-0.30</td><td>-1.34</td><td>0.116</td><td>0.199</td><td>1.000</td><td>5291</td><td>tags=44%, list=39%, signal=71%</td></tr><tr><td class='lessen'>111</td><td>DUTTA_APOPTOSIS_VIA_NFKB</td><td></td><td>22</td><td>-0.35</td><td>-1.34</td><td>0.119</td><td>0.199</td><td>1.000</td><td>7412</td><td>tags=73%, list=54%, signal=158%</td></tr><tr><td class='lessen'>112</td><td>GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP</td><td></td><td>118</td><td>-0.24</td><td>-1.34</td><td>0.071</td><td>0.199</td><td>1.000</td><td>5564</td><td>tags=49%, list=41%, signal=82%</td></tr><tr><td class='lessen'>113</td><td>GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN</td><td></td><td>162</td><td>-0.23</td><td>-1.33</td><td>0.055</td><td>0.200</td><td>1.000</td><td>7596</td><td>tags=67%, list=55%, signal=149%</td></tr><tr><td class='lessen'>114</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN</td><td></td><td>130</td><td>-0.23</td><td>-1.33</td><td>0.081</td><td>0.202</td><td>1.000</td><td>3493</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>115</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN</td><td></td><td>115</td><td>-0.24</td><td>-1.33</td><td>0.084</td><td>0.205</td><td>1.000</td><td>3332</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>116</td><td>HP_CONSTITUTIONAL_SYMPTOM</td><td></td><td>577</td><td>-0.19</td><td>-1.32</td><td>0.013</td><td>0.206</td><td>1.000</td><td>6481</td><td>tags=50%, list=47%, signal=91%</td></tr><tr><td class='lessen'>117</td><td>GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP</td><td></td><td>113</td><td>-0.24</td><td>-1.32</td><td>0.081</td><td>0.210</td><td>1.000</td><td>6518</td><td>tags=55%, list=48%, signal=104%</td></tr><tr><td class='lessen'>118</td><td>WANG_RECURRENT_LIVER_CANCER_DN</td><td></td><td>15</td><td>-0.40</td><td>-1.32</td><td>0.151</td><td>0.213</td><td>1.000</td><td>5682</td><td>tags=67%, list=41%, signal=114%</td></tr><tr><td class='lessen'>119</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP</td><td></td><td>129</td><td>-0.23</td><td>-1.32</td><td>0.074</td><td>0.212</td><td>1.000</td><td>6825</td><td>tags=58%, list=50%, signal=115%</td></tr><tr><td class='lessen'>120</td><td>GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP</td><td></td><td>128</td><td>-0.23</td><td>-1.31</td><td>0.073</td><td>0.214</td><td>1.000</td><td>6674</td><td>tags=59%, list=49%, signal=113%</td></tr><tr><td class='lessen'>121</td><td>GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP</td><td></td><td>124</td><td>-0.23</td><td>-1.31</td><td>0.064</td><td>0.212</td><td>1.000</td><td>5435</td><td>tags=47%, list=40%, signal=77%</td></tr><tr><td class='lessen'>122</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP</td><td></td><td>124</td><td>-0.23</td><td>-1.31</td><td>0.087</td><td>0.214</td><td>1.000</td><td>5873</td><td>tags=48%, list=43%, signal=83%</td></tr><tr><td class='lessen'>123</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>200</td><td>-0.21</td><td>-1.31</td><td>0.063</td><td>0.214</td><td>1.000</td><td>2350</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>124</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>152</td><td>-0.22</td><td>-1.30</td><td>0.068</td><td>0.219</td><td>1.000</td><td>3833</td><td>tags=36%, list=28%, signal=50%</td></tr><tr><td class='lessen'>125</td><td>GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN</td><td></td><td>101</td><td>-0.24</td><td>-1.30</td><td>0.099</td><td>0.221</td><td>1.000</td><td>3602</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>126</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>42</td><td>-0.29</td><td>-1.29</td><td>0.138</td><td>0.237</td><td>1.000</td><td>7219</td><td>tags=71%, list=53%, signal=151%</td></tr><tr><td class='lessen'>127</td><td>SWEET_KRAS_TARGETS_DN</td><td></td><td>46</td><td>-0.28</td><td>-1.29</td><td>0.136</td><td>0.237</td><td>1.000</td><td>7875</td><td>tags=78%, list=57%, signal=184%</td></tr><tr><td class='lessen'>128</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>128</td><td>-0.22</td><td>-1.28</td><td>0.106</td><td>0.251</td><td>1.000</td><td>7817</td><td>tags=66%, list=57%, signal=153%</td></tr><tr><td class='lessen'>129</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP</td><td></td><td>122</td><td>-0.22</td><td>-1.28</td><td>0.117</td><td>0.249</td><td>1.000</td><td>5820</td><td>tags=48%, list=42%, signal=83%</td></tr><tr><td class='lessen'>130</td><td>BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS</td><td></td><td>26</td><td>-0.32</td><td>-1.28</td><td>0.157</td><td>0.250</td><td>1.000</td><td>2796</td><td>tags=42%, list=20%, signal=53%</td></tr><tr><td class='lessen'>131</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN</td><td></td><td>101</td><td>-0.24</td><td>-1.27</td><td>0.105</td><td>0.250</td><td>1.000</td><td>3887</td><td>tags=36%, list=28%, signal=49%</td></tr><tr><td class='lessen'>132</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP</td><td></td><td>137</td><td>-0.22</td><td>-1.27</td><td>0.093</td><td>0.258</td><td>1.000</td><td>6808</td><td>tags=55%, list=50%, signal=108%</td></tr><tr><td class='lessen'>133</td><td>VILLANUEVA_LIVER_CANCER_KRT19_DN</td><td></td><td>53</td><td>-0.27</td><td>-1.27</td><td>0.149</td><td>0.257</td><td>1.000</td><td>7481</td><td>tags=70%, list=55%, signal=153%</td></tr><tr><td class='lessen'>134</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>219</td><td>-0.20</td><td>-1.27</td><td>0.092</td><td>0.257</td><td>1.000</td><td>5631</td><td>tags=48%, list=41%, signal=81%</td></tr><tr><td class='lessen'>135</td><td>GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN</td><td></td><td>146</td><td>-0.22</td><td>-1.26</td><td>0.122</td><td>0.267</td><td>1.000</td><td>4814</td><td>tags=41%, list=35%, signal=63%</td></tr><tr><td class='lessen'>136</td><td>FAELT_B_CLL_WITH_VH3_21_DN</td><td></td><td>38</td><td>-0.29</td><td>-1.26</td><td>0.175</td><td>0.269</td><td>1.000</td><td>5687</td><td>tags=61%, list=42%, signal=103%</td></tr><tr><td class='lessen'>137</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP</td><td></td><td>154</td><td>-0.21</td><td>-1.25</td><td>0.117</td><td>0.273</td><td>1.000</td><td>5661</td><td>tags=47%, list=41%, signal=79%</td></tr><tr><td class='lessen'>138</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>160</td><td>-0.21</td><td>-1.25</td><td>0.117</td><td>0.272</td><td>1.000</td><td>6019</td><td>tags=49%, list=44%, signal=87%</td></tr><tr><td class='lessen'>139</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>188</td><td>-0.20</td><td>-1.24</td><td>0.120</td><td>0.293</td><td>1.000</td><td>5641</td><td>tags=46%, list=41%, signal=77%</td></tr><tr><td class='lessen'>140</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN</td><td></td><td>126</td><td>-0.22</td><td>-1.23</td><td>0.150</td><td>0.293</td><td>1.000</td><td>4124</td><td>tags=39%, list=30%, signal=55%</td></tr><tr><td class='lessen'>141</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN</td><td></td><td>36</td><td>-0.29</td><td>-1.23</td><td>0.190</td><td>0.292</td><td>1.000</td><td>5549</td><td>tags=56%, list=41%, signal=93%</td></tr><tr><td class='lessen'>142</td><td>GSE15659_RESTING_VS_ACTIVATED_TREG_UP</td><td></td><td>113</td><td>-0.22</td><td>-1.23</td><td>0.149</td><td>0.293</td><td>1.000</td><td>5564</td><td>tags=44%, list=41%, signal=74%</td></tr><tr><td class='lessen'>143</td><td>REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE</td><td></td><td>34</td><td>-0.29</td><td>-1.23</td><td>0.192</td><td>0.296</td><td>1.000</td><td>4790</td><td>tags=41%, list=35%, signal=63%</td></tr><tr><td class='lessen'>144</td><td>GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP</td><td></td><td>115</td><td>-0.22</td><td>-1.23</td><td>0.148</td><td>0.294</td><td>1.000</td><td>6825</td><td>tags=57%, list=50%, signal=113%</td></tr><tr><td class='lessen'>145</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP</td><td></td><td>153</td><td>-0.21</td><td>-1.22</td><td>0.152</td><td>0.304</td><td>1.000</td><td>6117</td><td>tags=53%, list=45%, signal=95%</td></tr><tr><td class='lessen'>146</td><td>GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN</td><td></td><td>91</td><td>-0.23</td><td>-1.22</td><td>0.172</td><td>0.307</td><td>1.000</td><td>6348</td><td>tags=55%, list=46%, signal=102%</td></tr><tr><td class='lessen'>147</td><td>FRASOR_TAMOXIFEN_RESPONSE_UP</td><td></td><td>31</td><td>-0.30</td><td>-1.21</td><td>0.213</td><td>0.313</td><td>1.000</td><td>3847</td><td>tags=42%, list=28%, signal=58%</td></tr><tr><td class='lessen'>148</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>25</td><td>-0.31</td><td>-1.21</td><td>0.211</td><td>0.316</td><td>1.000</td><td>3893</td><td>tags=44%, list=28%, signal=61%</td></tr><tr><td class='lessen'>149</td><td>SU_THYMUS</td><td></td><td>17</td><td>-0.36</td><td>-1.21</td><td>0.241</td><td>0.316</td><td>1.000</td><td>6758</td><td>tags=71%, list=49%, signal=139%</td></tr><tr><td class='lessen'>150</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN</td><td></td><td>116</td><td>-0.21</td><td>-1.20</td><td>0.181</td><td>0.323</td><td>1.000</td><td>5607</td><td>tags=48%, list=41%, signal=81%</td></tr><tr><td class='lessen'>151</td><td>HP_CLINICAL_COURSE</td><td></td><td>884</td><td>-0.17</td><td>-1.20</td><td>0.060</td><td>0.331</td><td>1.000</td><td>6847</td><td>tags=53%, list=50%, signal=99%</td></tr><tr><td class='lessen'>152</td><td>GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN</td><td></td><td>105</td><td>-0.22</td><td>-1.20</td><td>0.188</td><td>0.329</td><td>1.000</td><td>2529</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>153</td><td>GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP</td><td></td><td>133</td><td>-0.21</td><td>-1.20</td><td>0.168</td><td>0.331</td><td>1.000</td><td>6457</td><td>tags=53%, list=47%, signal=99%</td></tr><tr><td class='lessen'>154</td><td>HP_CHILDHOOD_ONSET</td><td></td><td>29</td><td>-0.30</td><td>-1.20</td><td>0.230</td><td>0.329</td><td>1.000</td><td>5518</td><td>tags=55%, list=40%, signal=92%</td></tr><tr><td class='lessen'>155</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>25</td><td>-0.31</td><td>-1.19</td><td>0.250</td><td>0.338</td><td>1.000</td><td>3797</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>156</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP</td><td></td><td>24</td><td>-0.31</td><td>-1.19</td><td>0.234</td><td>0.338</td><td>1.000</td><td>6863</td><td>tags=75%, list=50%, signal=150%</td></tr><tr><td class='lessen'>157</td><td>WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE</td><td></td><td>17</td><td>-0.34</td><td>-1.18</td><td>0.254</td><td>0.349</td><td>1.000</td><td>7457</td><td>tags=82%, list=54%, signal=181%</td></tr><tr><td class='lessen'>158</td><td>KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION</td><td></td><td>21</td><td>-0.32</td><td>-1.18</td><td>0.234</td><td>0.352</td><td>1.000</td><td>8120</td><td>tags=67%, list=59%, signal=163%</td></tr><tr><td class='lessen'>159</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>176</td><td>-0.20</td><td>-1.18</td><td>0.176</td><td>0.352</td><td>1.000</td><td>6099</td><td>tags=50%, list=45%, signal=89%</td></tr><tr><td class='lessen'>160</td><td>HP_PEDIATRIC_ONSET</td><td></td><td>369</td><td>-0.18</td><td>-1.17</td><td>0.151</td><td>0.363</td><td>1.000</td><td>6847</td><td>tags=54%, list=50%, signal=104%</td></tr><tr><td class='lessen'>161</td><td>MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN</td><td></td><td>16</td><td>-0.35</td><td>-1.17</td><td>0.266</td><td>0.366</td><td>1.000</td><td>5424</td><td>tags=63%, list=40%, signal=103%</td></tr><tr><td class='lessen'>162</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td><td></td><td>32</td><td>-0.28</td><td>-1.17</td><td>0.261</td><td>0.365</td><td>1.000</td><td>7600</td><td>tags=69%, list=55%, signal=154%</td></tr><tr><td class='lessen'>163</td><td>MCLACHLAN_DENTAL_CARIES_DN</td><td></td><td>40</td><td>-0.26</td><td>-1.17</td><td>0.249</td><td>0.364</td><td>1.000</td><td>8474</td><td>tags=73%, list=62%, signal=190%</td></tr><tr><td class='lessen'>164</td><td>HP_INFANTILE_ONSET</td><td></td><td>291</td><td>-0.18</td><td>-1.16</td><td>0.172</td><td>0.365</td><td>1.000</td><td>6847</td><td>tags=55%, list=50%, signal=107%</td></tr><tr><td class='lessen'>165</td><td>GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN</td><td></td><td>130</td><td>-0.21</td><td>-1.16</td><td>0.209</td><td>0.364</td><td>1.000</td><td>6710</td><td>tags=58%, list=49%, signal=112%</td></tr><tr><td class='lessen'>166</td><td>HP_RICKETS</td><td></td><td>23</td><td>-0.31</td><td>-1.16</td><td>0.266</td><td>0.378</td><td>1.000</td><td>5900</td><td>tags=61%, list=43%, signal=107%</td></tr><tr><td class='lessen'>167</td><td>GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN</td><td></td><td>131</td><td>-0.20</td><td>-1.15</td><td>0.219</td><td>0.386</td><td>1.000</td><td>5357</td><td>tags=47%, list=39%, signal=76%</td></tr><tr><td class='lessen'>168</td><td>ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN</td><td></td><td>60</td><td>-0.24</td><td>-1.15</td><td>0.270</td><td>0.390</td><td>1.000</td><td>7512</td><td>tags=63%, list=55%, signal=140%</td></tr><tr><td class='lessen'>169</td><td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td><td></td><td>67</td><td>-0.23</td><td>-1.15</td><td>0.271</td><td>0.390</td><td>1.000</td><td>6079</td><td>tags=49%, list=44%, signal=88%</td></tr><tr><td class='lessen'>170</td><td>GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN</td><td></td><td>98</td><td>-0.21</td><td>-1.14</td><td>0.231</td><td>0.390</td><td>1.000</td><td>3846</td><td>tags=34%, list=28%, signal=46%</td></tr><tr><td class='lessen'>171</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_UP</td><td></td><td>36</td><td>-0.26</td><td>-1.14</td><td>0.281</td><td>0.392</td><td>1.000</td><td>5059</td><td>tags=53%, list=37%, signal=83%</td></tr><tr><td class='lessen'>172</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN</td><td></td><td>117</td><td>-0.20</td><td>-1.14</td><td>0.240</td><td>0.390</td><td>1.000</td><td>4249</td><td>tags=38%, list=31%, signal=54%</td></tr><tr><td class='lessen'>173</td><td>HP_ONSET</td><td></td><td>639</td><td>-0.17</td><td>-1.14</td><td>0.156</td><td>0.391</td><td>1.000</td><td>6865</td><td>tags=54%, list=50%, signal=103%</td></tr><tr><td class='lessen'>174</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td><td></td><td>32</td><td>-0.26</td><td>-1.12</td><td>0.306</td><td>0.419</td><td>1.000</td><td>1174</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>175</td><td>GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN</td><td></td><td>132</td><td>-0.19</td><td>-1.12</td><td>0.275</td><td>0.431</td><td>1.000</td><td>6874</td><td>tags=59%, list=50%, signal=117%</td></tr><tr><td class='lessen'>176</td><td>GSE15659_TREG_VS_TCONV_UP</td><td></td><td>114</td><td>-0.20</td><td>-1.12</td><td>0.288</td><td>0.430</td><td>1.000</td><td>6703</td><td>tags=56%, list=49%, signal=109%</td></tr><tr><td class='lessen'>177</td><td>GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP</td><td></td><td>77</td><td>-0.22</td><td>-1.11</td><td>0.309</td><td>0.443</td><td>1.000</td><td>5874</td><td>tags=52%, list=43%, signal=90%</td></tr><tr><td class='lessen'>178</td><td>ZHAN_MULTIPLE_MYELOMA_MS_UP</td><td></td><td>25</td><td>-0.28</td><td>-1.11</td><td>0.317</td><td>0.448</td><td>1.000</td><td>7022</td><td>tags=64%, list=51%, signal=131%</td></tr><tr><td class='lessen'>179</td><td>GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP</td><td></td><td>139</td><td>-0.19</td><td>-1.10</td><td>0.308</td><td>0.460</td><td>1.000</td><td>4377</td><td>tags=35%, list=32%, signal=50%</td></tr><tr><td class='lessen'>180</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP</td><td></td><td>19</td><td>-0.31</td><td>-1.09</td><td>0.373</td><td>0.473</td><td>1.000</td><td>6660</td><td>tags=79%, list=49%, signal=153%</td></tr><tr><td class='lessen'>181</td><td>GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP</td><td></td><td>128</td><td>-0.19</td><td>-1.09</td><td>0.333</td><td>0.474</td><td>1.000</td><td>6590</td><td>tags=55%, list=48%, signal=106%</td></tr><tr><td class='lessen'>182</td><td>ZHAN_MULTIPLE_MYELOMA_LB_DN</td><td></td><td>24</td><td>-0.29</td><td>-1.09</td><td>0.361</td><td>0.477</td><td>1.000</td><td>2531</td><td>tags=42%, list=18%, signal=51%</td></tr><tr><td class='lessen'>183</td><td>VANTVEER_BREAST_CANCER_METASTASIS_UP</td><td></td><td>30</td><td>-0.26</td><td>-1.08</td><td>0.361</td><td>0.488</td><td>1.000</td><td>6043</td><td>tags=53%, list=44%, signal=95%</td></tr><tr><td class='lessen'>184</td><td>GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN</td><td></td><td>137</td><td>-0.19</td><td>-1.07</td><td>0.335</td><td>0.496</td><td>1.000</td><td>4272</td><td>tags=34%, list=31%, signal=49%</td></tr><tr><td class='lessen'>185</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_UP</td><td></td><td>25</td><td>-0.28</td><td>-1.07</td><td>0.368</td><td>0.499</td><td>1.000</td><td>5607</td><td>tags=48%, list=41%, signal=81%</td></tr><tr><td class='lessen'>186</td><td>SU_PLACENTA</td><td></td><td>18</td><td>-0.30</td><td>-1.07</td><td>0.381</td><td>0.504</td><td>1.000</td><td>9224</td><td>tags=94%, list=67%, signal=289%</td></tr><tr><td class='lessen'>187</td><td>GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP</td><td></td><td>110</td><td>-0.19</td><td>-1.07</td><td>0.361</td><td>0.504</td><td>1.000</td><td>8455</td><td>tags=65%, list=62%, signal=170%</td></tr><tr><td class='lessen'>188</td><td>HP_ABNORMAL_INTESTINE_MORPHOLOGY</td><td></td><td>382</td><td>-0.16</td><td>-1.06</td><td>0.351</td><td>0.511</td><td>1.000</td><td>6608</td><td>tags=52%, list=48%, signal=97%</td></tr><tr><td class='lessen'>189</td><td>HP_ADULT_ONSET</td><td></td><td>97</td><td>-0.19</td><td>-1.06</td><td>0.362</td><td>0.516</td><td>1.000</td><td>7099</td><td>tags=64%, list=52%, signal=132%</td></tr><tr><td class='lessen'>190</td><td>RAGHAVACHARI_PLATELET_SPECIFIC_GENES</td><td></td><td>56</td><td>-0.22</td><td>-1.05</td><td>0.368</td><td>0.525</td><td>1.000</td><td>3349</td><td>tags=34%, list=24%, signal=45%</td></tr><tr><td class='lessen'>191</td><td>HP_OSTEOPOROSIS</td><td></td><td>164</td><td>-0.18</td><td>-1.05</td><td>0.388</td><td>0.538</td><td>1.000</td><td>8690</td><td>tags=71%, list=63%, signal=193%</td></tr><tr><td class='lessen'>192</td><td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td><td></td><td>23</td><td>-0.28</td><td>-1.04</td><td>0.407</td><td>0.542</td><td>1.000</td><td>4648</td><td>tags=61%, list=34%, signal=92%</td></tr><tr><td class='lessen'>193</td><td>GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN</td><td></td><td>126</td><td>-0.18</td><td>-1.03</td><td>0.404</td><td>0.558</td><td>1.000</td><td>7500</td><td>tags=60%, list=55%, signal=130%</td></tr><tr><td class='lessen'>194</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td><td></td><td>34</td><td>-0.25</td><td>-1.03</td><td>0.427</td><td>0.556</td><td>1.000</td><td>8048</td><td>tags=76%, list=59%, signal=185%</td></tr><tr><td class='lessen'>195</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP</td><td></td><td>65</td><td>-0.21</td><td>-1.03</td><td>0.436</td><td>0.558</td><td>1.000</td><td>5537</td><td>tags=51%, list=40%, signal=85%</td></tr><tr><td class='lessen'>196</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP</td><td></td><td>86</td><td>-0.19</td><td>-1.03</td><td>0.413</td><td>0.557</td><td>1.000</td><td>6617</td><td>tags=53%, list=48%, signal=103%</td></tr><tr><td class='lessen'>197</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>31</td><td>-0.24</td><td>-1.02</td><td>0.433</td><td>0.575</td><td>1.000</td><td>3649</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>198</td><td>SU_LIVER</td><td></td><td>50</td><td>-0.22</td><td>-1.02</td><td>0.450</td><td>0.577</td><td>1.000</td><td>8629</td><td>tags=72%, list=63%, signal=194%</td></tr><tr><td class='lessen'>199</td><td>CROMER_METASTASIS_UP</td><td></td><td>41</td><td>-0.23</td><td>-1.02</td><td>0.429</td><td>0.579</td><td>1.000</td><td>3144</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>200</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN</td><td></td><td>96</td><td>-0.19</td><td>-1.01</td><td>0.428</td><td>0.578</td><td>1.000</td><td>6087</td><td>tags=49%, list=44%, signal=88%</td></tr><tr><td class='lessen'>201</td><td>BILD_HRAS_ONCOGENIC_SIGNATURE</td><td></td><td>153</td><td>-0.17</td><td>-1.01</td><td>0.435</td><td>0.578</td><td>1.000</td><td>7245</td><td>tags=58%, list=53%, signal=122%</td></tr><tr><td class='lessen'>202</td><td>GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP</td><td></td><td>112</td><td>-0.18</td><td>-1.00</td><td>0.445</td><td>0.597</td><td>1.000</td><td>5904</td><td>tags=45%, list=43%, signal=78%</td></tr><tr><td class='lessen'>203</td><td>HP_RESTRICTIVE_VENTILATORY_DEFECT</td><td></td><td>30</td><td>-0.24</td><td>-1.00</td><td>0.457</td><td>0.603</td><td>1.000</td><td>3913</td><td>tags=30%, list=29%, signal=42%</td></tr><tr><td class='lessen'>204</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>28</td><td>-0.25</td><td>-1.00</td><td>0.468</td><td>0.600</td><td>1.000</td><td>7161</td><td>tags=61%, list=52%, signal=127%</td></tr><tr><td class='lessen'>205</td><td>CHANDRAN_METASTASIS_DN</td><td></td><td>212</td><td>-0.16</td><td>-1.00</td><td>0.486</td><td>0.603</td><td>1.000</td><td>4303</td><td>tags=33%, list=31%, signal=47%</td></tr><tr><td class='lessen'>206</td><td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td><td></td><td>26</td><td>-0.26</td><td>-1.00</td><td>0.485</td><td>0.603</td><td>1.000</td><td>7997</td><td>tags=81%, list=58%, signal=194%</td></tr><tr><td class='lessen'>207</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</td><td></td><td>43</td><td>-0.22</td><td>-0.99</td><td>0.485</td><td>0.605</td><td>1.000</td><td>4792</td><td>tags=44%, list=35%, signal=68%</td></tr><tr><td class='lessen'>208</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_DN</td><td></td><td>28</td><td>-0.24</td><td>-0.99</td><td>0.478</td><td>0.617</td><td>1.000</td><td>6701</td><td>tags=61%, list=49%, signal=119%</td></tr><tr><td class='lessen'>209</td><td>GSE15659_TREG_VS_TCONV_DN</td><td></td><td>109</td><td>-0.18</td><td>-0.98</td><td>0.519</td><td>0.626</td><td>1.000</td><td>3918</td><td>tags=33%, list=29%, signal=46%</td></tr><tr><td class='lessen'>210</td><td>GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP</td><td></td><td>74</td><td>-0.19</td><td>-0.97</td><td>0.508</td><td>0.648</td><td>1.000</td><td>5803</td><td>tags=47%, list=42%, signal=82%</td></tr><tr><td class='lessen'>211</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td><td></td><td>17</td><td>-0.28</td><td>-0.95</td><td>0.524</td><td>0.681</td><td>1.000</td><td>783</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>212</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td><td></td><td>63</td><td>-0.19</td><td>-0.93</td><td>0.572</td><td>0.718</td><td>1.000</td><td>7323</td><td>tags=60%, list=53%, signal=129%</td></tr><tr><td class='lessen'>213</td><td>GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP</td><td></td><td>98</td><td>-0.17</td><td>-0.93</td><td>0.555</td><td>0.716</td><td>1.000</td><td>4751</td><td>tags=37%, list=35%, signal=56%</td></tr><tr><td class='lessen'>214</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td><td></td><td>41</td><td>-0.21</td><td>-0.93</td><td>0.564</td><td>0.713</td><td>1.000</td><td>3689</td><td>tags=39%, list=27%, signal=53%</td></tr><tr><td class='lessen'>215</td><td>GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP</td><td></td><td>123</td><td>-0.17</td><td>-0.93</td><td>0.606</td><td>0.722</td><td>1.000</td><td>6097</td><td>tags=48%, list=45%, signal=86%</td></tr><tr><td class='lessen'>216</td><td>HP_FASCICULATIONS</td><td></td><td>43</td><td>-0.20</td><td>-0.93</td><td>0.557</td><td>0.722</td><td>1.000</td><td>7353</td><td>tags=65%, list=54%, signal=140%</td></tr><tr><td class='lessen'>217</td><td>HP_JUVENILE_ONSET</td><td></td><td>65</td><td>-0.19</td><td>-0.92</td><td>0.574</td><td>0.727</td><td>1.000</td><td>3325</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>218</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td><td></td><td>304</td><td>-0.14</td><td>-0.92</td><td>0.660</td><td>0.728</td><td>1.000</td><td>5674</td><td>tags=44%, list=41%, signal=73%</td></tr><tr><td class='lessen'>219</td><td>GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP</td><td></td><td>111</td><td>-0.16</td><td>-0.91</td><td>0.606</td><td>0.741</td><td>1.000</td><td>2712</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>220</td><td>GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN</td><td></td><td>78</td><td>-0.17</td><td>-0.91</td><td>0.613</td><td>0.742</td><td>1.000</td><td>7630</td><td>tags=58%, list=56%, signal=130%</td></tr><tr><td class='lessen'>221</td><td>SWEET_KRAS_TARGETS_UP</td><td></td><td>52</td><td>-0.19</td><td>-0.91</td><td>0.622</td><td>0.743</td><td>1.000</td><td>5790</td><td>tags=44%, list=42%, signal=76%</td></tr><tr><td class='lessen'>222</td><td>HP_STAGE_5_CHRONIC_KIDNEY_DISEASE</td><td></td><td>34</td><td>-0.21</td><td>-0.91</td><td>0.593</td><td>0.744</td><td>1.000</td><td>5927</td><td>tags=56%, list=43%, signal=98%</td></tr><tr><td class='lessen'>223</td><td>GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN</td><td></td><td>137</td><td>-0.16</td><td>-0.90</td><td>0.637</td><td>0.745</td><td>1.000</td><td>5834</td><td>tags=47%, list=43%, signal=81%</td></tr><tr><td class='lessen'>224</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP</td><td></td><td>15</td><td>-0.28</td><td>-0.90</td><td>0.593</td><td>0.743</td><td>1.000</td><td>5473</td><td>tags=53%, list=40%, signal=89%</td></tr><tr><td class='lessen'>225</td><td>GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN</td><td></td><td>92</td><td>-0.17</td><td>-0.89</td><td>0.660</td><td>0.761</td><td>1.000</td><td>4559</td><td>tags=34%, list=33%, signal=50%</td></tr><tr><td class='lessen'>226</td><td>ALONSO_METASTASIS_EMT_UP</td><td></td><td>27</td><td>-0.22</td><td>-0.89</td><td>0.613</td><td>0.765</td><td>1.000</td><td>2692</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>227</td><td>HP_CHRONIC_KIDNEY_DISEASE</td><td></td><td>43</td><td>-0.20</td><td>-0.88</td><td>0.631</td><td>0.785</td><td>1.000</td><td>5927</td><td>tags=56%, list=43%, signal=98%</td></tr><tr><td class='lessen'>228</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>22</td><td>-0.23</td><td>-0.87</td><td>0.630</td><td>0.793</td><td>1.000</td><td>8226</td><td>tags=68%, list=60%, signal=170%</td></tr><tr><td class='lessen'>229</td><td>ANDERSEN_LIVER_CANCER_KRT19_DN</td><td></td><td>66</td><td>-0.17</td><td>-0.87</td><td>0.685</td><td>0.798</td><td>1.000</td><td>6465</td><td>tags=52%, list=47%, signal=97%</td></tr><tr><td class='lessen'>230</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</td><td></td><td>38</td><td>-0.20</td><td>-0.86</td><td>0.679</td><td>0.804</td><td>1.000</td><td>6069</td><td>tags=53%, list=44%, signal=94%</td></tr><tr><td class='lessen'>231</td><td>SPIRA_SMOKERS_LUNG_CANCER_UP</td><td></td><td>31</td><td>-0.21</td><td>-0.86</td><td>0.665</td><td>0.804</td><td>1.000</td><td>4576</td><td>tags=42%, list=33%, signal=63%</td></tr><tr><td class='lessen'>232</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td><td></td><td>68</td><td>-0.17</td><td>-0.85</td><td>0.714</td><td>0.812</td><td>1.000</td><td>8169</td><td>tags=66%, list=60%, signal=163%</td></tr><tr><td class='lessen'>233</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN</td><td></td><td>188</td><td>-0.14</td><td>-0.85</td><td>0.764</td><td>0.813</td><td>1.000</td><td>6585</td><td>tags=49%, list=48%, signal=94%</td></tr><tr><td class='lessen'>234</td><td>WP_WNT_SIGNALING_IN_KIDNEY_DISEASE</td><td></td><td>31</td><td>-0.21</td><td>-0.85</td><td>0.678</td><td>0.811</td><td>1.000</td><td>8376</td><td>tags=58%, list=61%, signal=149%</td></tr><tr><td class='lessen'>235</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>218</td><td>-0.14</td><td>-0.84</td><td>0.781</td><td>0.826</td><td>1.000</td><td>6445</td><td>tags=52%, list=47%, signal=96%</td></tr><tr><td class='lessen'>236</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_UP</td><td></td><td>37</td><td>-0.19</td><td>-0.82</td><td>0.717</td><td>0.851</td><td>1.000</td><td>4567</td><td>tags=38%, list=33%, signal=57%</td></tr><tr><td class='lessen'>237</td><td>KIM_LIVER_CANCER_POOR_SURVIVAL_UP</td><td></td><td>19</td><td>-0.23</td><td>-0.81</td><td>0.724</td><td>0.861</td><td>1.000</td><td>2536</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>238</td><td>HP_PATHOLOGIC_FRACTURE</td><td></td><td>19</td><td>-0.22</td><td>-0.81</td><td>0.731</td><td>0.862</td><td>1.000</td><td>949</td><td>tags=21%, list=7%, signal=23%</td></tr><tr><td class='lessen'>239</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP</td><td></td><td>47</td><td>-0.18</td><td>-0.80</td><td>0.748</td><td>0.868</td><td>1.000</td><td>5041</td><td>tags=43%, list=37%, signal=67%</td></tr><tr><td class='lessen'>240</td><td>GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN</td><td></td><td>143</td><td>-0.14</td><td>-0.80</td><td>0.816</td><td>0.872</td><td>1.000</td><td>8418</td><td>tags=64%, list=61%, signal=163%</td></tr><tr><td class='lessen'>241</td><td>KIM_LIVER_CANCER_POOR_SURVIVAL_DN</td><td></td><td>36</td><td>-0.18</td><td>-0.79</td><td>0.785</td><td>0.885</td><td>1.000</td><td>6465</td><td>tags=53%, list=47%, signal=100%</td></tr><tr><td class='lessen'>242</td><td>KEGG_DILATED_CARDIOMYOPATHY</td><td></td><td>43</td><td>-0.17</td><td>-0.78</td><td>0.791</td><td>0.896</td><td>1.000</td><td>6469</td><td>tags=49%, list=47%, signal=92%</td></tr><tr><td class='lessen'>243</td><td>GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP</td><td></td><td>83</td><td>-0.15</td><td>-0.78</td><td>0.829</td><td>0.895</td><td>1.000</td><td>7802</td><td>tags=61%, list=57%, signal=142%</td></tr><tr><td class='lessen'>244</td><td>VANTVEER_BREAST_CANCER_ESR1_UP</td><td></td><td>83</td><td>-0.14</td><td>-0.76</td><td>0.844</td><td>0.916</td><td>1.000</td><td>6428</td><td>tags=48%, list=47%, signal=90%</td></tr><tr><td class='lessen'>245</td><td>GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP</td><td></td><td>111</td><td>-0.13</td><td>-0.74</td><td>0.893</td><td>0.934</td><td>1.000</td><td>7769</td><td>tags=58%, list=57%, signal=132%</td></tr><tr><td class='lessen'>246</td><td>ZHAN_MULTIPLE_MYELOMA_HP_UP</td><td></td><td>30</td><td>-0.18</td><td>-0.74</td><td>0.824</td><td>0.938</td><td>1.000</td><td>7767</td><td>tags=70%, list=57%, signal=161%</td></tr><tr><td class='lessen'>247</td><td>WALLACE_PROSTATE_CANCER_RACE_UP</td><td></td><td>224</td><td>-0.12</td><td>-0.73</td><td>0.935</td><td>0.936</td><td>1.000</td><td>2127</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>248</td><td>CHANDRAN_METASTASIS_TOP50_DN</td><td></td><td>28</td><td>-0.18</td><td>-0.72</td><td>0.839</td><td>0.949</td><td>1.000</td><td>3599</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>249</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</td><td></td><td>33</td><td>-0.17</td><td>-0.71</td><td>0.850</td><td>0.949</td><td>1.000</td><td>2811</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>250</td><td>CROMER_TUMORIGENESIS_UP</td><td></td><td>37</td><td>-0.16</td><td>-0.70</td><td>0.877</td><td>0.962</td><td>1.000</td><td>2103</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>251</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN</td><td></td><td>116</td><td>-0.12</td><td>-0.69</td><td>0.949</td><td>0.965</td><td>1.000</td><td>4400</td><td>tags=32%, list=32%, signal=47%</td></tr><tr><td class='lessen'>252</td><td>GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP</td><td></td><td>94</td><td>-0.13</td><td>-0.68</td><td>0.945</td><td>0.965</td><td>1.000</td><td>7172</td><td>tags=52%, list=52%, signal=109%</td></tr><tr><td class='lessen'>253</td><td>SU_PANCREAS</td><td></td><td>30</td><td>-0.17</td><td>-0.67</td><td>0.889</td><td>0.970</td><td>1.000</td><td>8396</td><td>tags=63%, list=61%, signal=163%</td></tr><tr><td class='lessen'>254</td><td>GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP</td><td></td><td>123</td><td>-0.12</td><td>-0.66</td><td>0.966</td><td>0.974</td><td>1.000</td><td>2393</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>255</td><td>HP_RETINOPATHY</td><td></td><td>81</td><td>-0.13</td><td>-0.66</td><td>0.956</td><td>0.971</td><td>1.000</td><td>7877</td><td>tags=60%, list=58%, signal=142%</td></tr><tr><td class='lessen'>256</td><td>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP</td><td></td><td>111</td><td>-0.12</td><td>-0.66</td><td>0.974</td><td>0.969</td><td>1.000</td><td>6741</td><td>tags=48%, list=49%, signal=93%</td></tr><tr><td class='lessen'>257</td><td>ZHAN_MULTIPLE_MYELOMA_DN</td><td></td><td>30</td><td>-0.15</td><td>-0.61</td><td>0.942</td><td>0.988</td><td>1.000</td><td>7068</td><td>tags=47%, list=52%, signal=96%</td></tr><tr><td class='lessen'>258</td><td>ANDERSEN_CHOLANGIOCARCINOMA_CLASS2</td><td></td><td>124</td><td>-0.10</td><td>-0.58</td><td>0.995</td><td>0.997</td><td>1.000</td><td>6966</td><td>tags=49%, list=51%, signal=99%</td></tr><tr><td class='lessen'>259</td><td>KEGG_VIRAL_MYOCARDITIS</td><td></td><td>46</td><td>-0.12</td><td>-0.56</td><td>0.996</td><td>0.998</td><td>1.000</td><td>12046</td><td>tags=100%, list=88%, signal=827%</td></tr><tr><td class='lessen'>260</td><td>MCLACHLAN_DENTAL_CARIES_UP</td><td></td><td>209</td><td>-0.09</td><td>-0.56</td><td>1.000</td><td>0.995</td><td>1.000</td><td>2261</td><td>tags=14%, list=17%, signal=16%</td></tr><tr><td class='lessen'>261</td><td>KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG</td><td></td><td>16</td><td>-0.15</td><td>-0.53</td><td>0.984</td><td>0.996</td><td>1.000</td><td>8260</td><td>tags=75%, list=60%, signal=189%</td></tr><tr><td class='lessen'>262</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_DN</td><td></td><td>33</td><td>-0.11</td><td>-0.48</td><td>0.997</td><td>0.997</td><td>1.000</td><td>8585</td><td>tags=67%, list=63%, signal=178%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1622800568542.tsv'>[plain text format]</a></caption></table></div><br></body></html>